Increasing the information provided by probabilistic sensitivity analysis: The relative density plot

被引：0
作者：
Joost W. Geenen
Rick A. Vreman
Cornelis Boersma
Olaf H. Klungel
Anke M. Hövels
Renske M. T. Ten Ham
机构：
[1] Utrecht Institute for Pharmaceutical Sciences (UIPS),Division of Pharmacoepidemiology and Clinical Pharmacology
[2] Utrecht University,Division of Global Health, Department of Health Sciences
[3] The National Health Care Institute (ZIN),undefined
[4] Health-Ecore,undefined
[5] University of Groningen,undefined
[6] University Medical Center Groningen,undefined
来源：
Cost Effectiveness and Resource Allocation | / 18卷
关键词：
Probabilistic sensitivity analysis; Relative density; Health economics; Modelling; Health technology assessment; Sensitivity analysis; Information; Knowledge; Uncertainty; Health;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 53 条
  • [1] Adalsteinsson E(2013)Benefits of probabilistic sensitivity analysis – a review of NICE decisions Journal of Market Access & Health Policy 1 21240-732
  • [2] Toumi M(2012)Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6 Med Decis Making 32 722-104
  • [3] Briggs AH(1994)Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis Health Econ 3 95-1426
  • [4] Weinstein MC(2018)Probabilistic sensitivity analysis in cost-effectiveness models: determining model convergence in cohort models PharmacoEconomics 36 1421-634
  • [5] Fenwick EAL(2015)Probabilistic sensitivity analysis in health economics Stat Methods Med Res 24 615-822
  • [6] Karnon J(2012)The Many Faces of a Scatterplot Theory and Method 79 807-1538
  • [7] Sculpher MJ(2013)Splatterplots: overcoming Overdraw in Scatter Plots NIH Public Access 19 1526-357
  • [8] Paltiel AD(2002)Modern Applied Statistics with S Springer 19 A636-551
  • [9] Briggs A(2016)Early HTA in Pharmacogenomics: a Case Example in Cardiovascular Drugs Value in Health 108 350-undefined
  • [10] Sculpher M(2018)Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen Breast Cancer Res Treat 69 546-undefined
123456